▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | GreenCity | Italian Channel Awards | Italian Project Awards | ...
InnovationOpenLab

Tempus Announces Medicare Coverage for Tempus|xT Across Solid Tumor and Hematologic Malignancies

Tempus, a leader in artificial intelligence and precision medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor, and the Molecular Diagnostics Services Program (MolDx) has ...

Business Wire

CHICAGO: Tempus, a leader in artificial intelligence and precision medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor, and the Molecular Diagnostics Services Program (MolDx) has approved coverage for Tempus|xT, Tempus’ 648-gene DNA sequencing panel, for use in solid tumor and hematologic malignancies, performed in Tempus’ CAP/CLIA laboratory located in Research Triangle Park in North Carolina.

xT is now covered for Medicare patients under the MolDx program for tumor-only as well as normal match sequencing in all solid tumors, and tumor sequencing for patients with myeloid and suspected myeloid malignancies. xT is covered for Medicare patients with advanced cancers who meet its clinical criteria for complete genomic profiling with next-generation sequencing (NGS) of tumor tissue to optimize treatment selection decisions.

“We’re pleased that Medicare is advancing coverage for biomarker testing for patients with both solid tumor and hematologic cancers,” said Eric Lefkofsky, Founder and CEO of Tempus. “This step provides wider access to the tools physicians need to optimize treatment decisions for their patients.”

xT is a DNA sequencing panel that provides a comprehensive view of patients’ genomic profiles, equipping physicians to make informed treatment decisions. The assay identifies clinically relevant alterations, immunotherapy biomarkers such as MSI and TMB, as well as incidental germline findings.

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Contacts

Erin Carron
Senior Director of Communications
communications@tempus.com

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

Metaverse: between fashion, ecommerce and real estate in Italy strong…

The European market for the metaverse will generate $119.35 billion in revenue. Companies must make themselves ready.

Italy's Space Economy ecosystem looks to the Moon

Italian Space Agency is developing a lunar habitation module that could be used in the NASA Artemis Space exploration program

Bravo Innovation Hub Palermo: 20 startups selected for acceleration

The acceleration program developed by MIMIT selected the best startups for the “New energy, green and clean tech” and “Inclusion, social impact and Health”…

Italian system integrator Var Group expands digital security services…

With the acquisition of 51% of the South Tyrolean company ICS, the business unit Digital Security will also strengthen its Security Operation Center

Most read

Italian system integrator Var Group expands digital security services…

With the acquisition of 51% of the South Tyrolean company ICS, the business unit Digital Security will also strengthen its Security Operation Center

Italy's Space Economy ecosystem looks to the Moon

Italian Space Agency is developing a lunar habitation module that could be used in the NASA Artemis Space exploration program

Metaverse: between fashion, ecommerce and real estate in Italy strong…

The European market for the metaverse will generate $119.35 billion in revenue. Companies must make themselves ready.

Bravo Innovation Hub Palermo: 20 startups selected for acceleration

The acceleration program developed by MIMIT selected the best startups for the “New energy, green and clean tech” and “Inclusion, social impact and Health”…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!